Drugs - real world outcomes

Keyphrases

Publications

volume 11, number 3, 2024

Freny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, Keith L Davis, Alpesh N Amin
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction. Drugs - real world outcomes 11 (3) (2024)
Sophia Sheikh, Taylor Munson, Gerard Garvan, Claire Layton, Dawn Sollee, Colleen Cowdery, Alexa Peterson, Lindsay Schaack Rothstein, Morgan Henson, Hayley Gartner, Michael Ujhelyi
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity. Drugs - real world outcomes 11 (3) (2024)
Joshua M Inglis, Gillian Caughey, Tilenka Thynne, Kate Brotherton, Danny Liew, Arduino A Mangoni, Sepehr Shakib
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - real world outcomes 11 (3) (2024)
Jose Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros-Pedros, Maria Reig, Ferràn Torres, Caridad Pontes
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study. Drugs - real world outcomes 11 (3) (2024)
Ruggero Bacchin, Marco Liccari, Mauro Catalan, Lucia Antonutti, Paolo Manganotti, Maria Chiara Malaguti, Bruno Giometto
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease. Drugs - real world outcomes 11 (3) (2024)
Rina Omata, Akane Asami, Azusa Hara, Hisashi Urushihara
Prescribing Cascades of Loop Diuretics and Anti-vertigo Drugs Following Treatment with Gabapentinoids and Benzodiazepines: Prescription Sequence Symmetry Analysis of a Large-Scale Claims Database Including Japanese Older Adults. Drugs - real world outcomes 11 (3) (2024)
Ching-Ya Huang, Ying-Shu You, Jian-Ming Lai, Cheng-Li Lin, Hsing-Yu Hsu, Yow-Wen Hsieh
The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case-Control Study in Taiwan. Drugs - real world outcomes 11 (3) (2024)
Jerome H Goldschmidt, Wan-Yu Tseng, Yunfei Wang, Janet Espirito, Anupama Vasudevan, Michelle Silver, Jackie Kwong, Ruchit Shah, Elizabeth Marrett
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy. Drugs - real world outcomes 11 (3) (2024)
Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison, Bruno Emond, Louise H Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D Chakravarty, Philip Mease
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors. Drugs - real world outcomes 11 (3) (2024)
Camilo Espinosa-Jovel, Natalia Valencia, Lisa Gaitán, Sandra Riveros
Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study. Drugs - real world outcomes 11 (3) (2024)
Jerome H Goldschmidt, Wan-Yu Tseng, Yunfei Wang, Janet Espirito, Anupama Vasudevan, Michelle Silver, Jackie Kwong, Ruchit Shah, Elizabeth Marrett
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy. Drugs - real world outcomes 11 (3) (2024)
Jerome H Goldschmidt, Wan-Yu Tseng, Yunfei Wang, Janet Espirito, Anupama Vasudevan, Michelle Silver, Jackie Kwong, Ruchit Shah, Elizabeth Marrett
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy. Drugs - real world outcomes 11 (3) (2024)
Marija Križić, Marina Popović, Tajana Silovski, Dorotea Grbin, Natalija Dedić Plavetić
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance. Drugs - real world outcomes 11 (3) (2024)
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes 11 (3) (2024)
Joshua M Inglis, Gillian Caughey, Tilenka Thynne, Kate Brotherton, Danny Liew, Arduino A Mangoni, Sepehr Shakib
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - real world outcomes 11 (3) (2024)
Dahyun Park, Sungho Bea, Ji-Hwan Bae, Hyesung Lee, Young June Choe, Ju Young Shin, Hoon Kim
PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase. Drugs - real world outcomes 11 (3) (2024)
Mark Lebwohl, Bruce Strober, Amy Schrader, Alvin H Li, Thomas Eckmann, Baojin Zhu, William N Malatestinic, Julie Birt, Meghan Feely, Andrew Blauvelt
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. Drugs - real world outcomes 11 (3) (2024)
Jose Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros-Pedros, Maria Reig, Ferràn Torres, Caridad Pontes
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study. Drugs - real world outcomes 11 (3) (2024)
Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison, Bruno Emond, Louise H Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D Chakravarty, Philip Mease
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors. Drugs - real world outcomes 11 (3) (2024)
Freny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, Keith L Davis, Alpesh N Amin
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction. Drugs - real world outcomes 11 (3) (2024)
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A. Drugs - real world outcomes 11 (3) (2024)
Tae Maeshima, Sayaka Aisu, Naoki Ohkura, Machiko Watanabe, Fumio Itagaki
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database. Drugs - real world outcomes 11 (3) (2024)
Ching-Ya Huang, Ying-Shu You, Jian-Ming Lai, Cheng-Li Lin, Hsing-Yu Hsu, Yow-Wen Hsieh
The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case-Control Study in Taiwan. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
Mark Lebwohl, Bruce Strober, Amy Schrader, Alvin H Li, Thomas Eckmann, Baojin Zhu, William N Malatestinic, Julie Birt, Meghan Feely, Andrew Blauvelt
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. Drugs - real world outcomes 11 (3) (2024)
Mark Lebwohl, Bruce Strober, Amy Schrader, Alvin H Li, Thomas Eckmann, Baojin Zhu, William N Malatestinic, Julie Birt, Meghan Feely, Andrew Blauvelt
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. Drugs - real world outcomes 11 (3) (2024)
James D Lewis, Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Ghadeer K Dawwas
The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
James D Lewis, Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Ghadeer K Dawwas
The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study. Drugs - real world outcomes 11 (3) (2024)
Dahyun Park, Sungho Bea, Ji-Hwan Bae, Hyesung Lee, Young June Choe, Ju Young Shin, Hoon Kim
PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase. Drugs - real world outcomes 11 (3) (2024)
Ching-Ya Huang, Ying-Shu You, Jian-Ming Lai, Cheng-Li Lin, Hsing-Yu Hsu, Yow-Wen Hsieh
The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case-Control Study in Taiwan. Drugs - real world outcomes 11 (3) (2024)
Sophia Sheikh, Taylor Munson, Gerard Garvan, Claire Layton, Dawn Sollee, Colleen Cowdery, Alexa Peterson, Lindsay Schaack Rothstein, Morgan Henson, Hayley Gartner, Michael Ujhelyi
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity. Drugs - real world outcomes 11 (3) (2024)
Yu-Wen Chang, Meng-Yun Tsai, Yu-Ping Chang, Chien-Chang Liao, Yu-Ting Lin, Chien-Hao Lai, Meng-Chih Lin, Kuo-Tung Huang
Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis. Drugs - real world outcomes 11 (3) (2024)
Ruggero Bacchin, Marco Liccari, Mauro Catalan, Lucia Antonutti, Paolo Manganotti, Maria Chiara Malaguti, Bruno Giometto
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease. Drugs - real world outcomes 11 (3) (2024)
Ruggero Bacchin, Marco Liccari, Mauro Catalan, Lucia Antonutti, Paolo Manganotti, Maria Chiara Malaguti, Bruno Giometto
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease. Drugs - real world outcomes 11 (3) (2024)
Tae Maeshima, Sayaka Aisu, Naoki Ohkura, Machiko Watanabe, Fumio Itagaki
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
Camilo Espinosa-Jovel, Natalia Valencia, Lisa Gaitán, Sandra Riveros
Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study. Drugs - real world outcomes 11 (3) (2024)
James D Lewis, Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Ghadeer K Dawwas
The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study. Drugs - real world outcomes 11 (3) (2024)
Marija Križić, Marina Popović, Tajana Silovski, Dorotea Grbin, Natalija Dedić Plavetić
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance. Drugs - real world outcomes 11 (3) (2024)
Joshua M Inglis, Gillian Caughey, Tilenka Thynne, Kate Brotherton, Danny Liew, Arduino A Mangoni, Sepehr Shakib
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - real world outcomes 11 (3) (2024)
Tae Maeshima, Sayaka Aisu, Naoki Ohkura, Machiko Watanabe, Fumio Itagaki
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database. Drugs - real world outcomes 11 (3) (2024)
Yu-Wen Chang, Meng-Yun Tsai, Yu-Ping Chang, Chien-Chang Liao, Yu-Ting Lin, Chien-Hao Lai, Meng-Chih Lin, Kuo-Tung Huang
Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis. Drugs - real world outcomes 11 (3) (2024)
Rina Omata, Akane Asami, Azusa Hara, Hisashi Urushihara
Prescribing Cascades of Loop Diuretics and Anti-vertigo Drugs Following Treatment with Gabapentinoids and Benzodiazepines: Prescription Sequence Symmetry Analysis of a Large-Scale Claims Database Including Japanese Older Adults. Drugs - real world outcomes 11 (3) (2024)
Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison, Bruno Emond, Louise H Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D Chakravarty, Philip Mease
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors. Drugs - real world outcomes 11 (3) (2024)
Camilo Espinosa-Jovel, Natalia Valencia, Lisa Gaitán, Sandra Riveros
Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study. Drugs - real world outcomes 11 (3) (2024)
Sophia Sheikh, Taylor Munson, Gerard Garvan, Claire Layton, Dawn Sollee, Colleen Cowdery, Alexa Peterson, Lindsay Schaack Rothstein, Morgan Henson, Hayley Gartner, Michael Ujhelyi
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity. Drugs - real world outcomes 11 (3) (2024)
Dahyun Park, Sungho Bea, Ji-Hwan Bae, Hyesung Lee, Young June Choe, Ju Young Shin, Hoon Kim
PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase. Drugs - real world outcomes 11 (3) (2024)
Marija Križić, Marina Popović, Tajana Silovski, Dorotea Grbin, Natalija Dedić Plavetić
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance. Drugs - real world outcomes 11 (3) (2024)
Jose Ríos, Víctor Sapena, Zoe Mariño, Jordi Bruix, Xavier Forns, Rosa Morros-Pedros, Maria Reig, Ferràn Torres, Caridad Pontes
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study. Drugs - real world outcomes 11 (3) (2024)